AR095503A1 - Inyección intratesticular de inmunógenos - Google Patents
Inyección intratesticular de inmunógenosInfo
- Publication number
- AR095503A1 AR095503A1 ARP140101108A ARP140101108A AR095503A1 AR 095503 A1 AR095503 A1 AR 095503A1 AR P140101108 A ARP140101108 A AR P140101108A AR P140101108 A ARP140101108 A AR P140101108A AR 095503 A1 AR095503 A1 AR 095503A1
- Authority
- AR
- Argentina
- Prior art keywords
- immunogen
- intratesticular
- amino acid
- composition
- immune response
- Prior art date
Links
- 230000002163 immunogen Effects 0.000 title abstract 3
- 238000002347 injection Methods 0.000 title abstract 2
- 239000007924 injection Substances 0.000 title abstract 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 229960000306 zinc gluconate Drugs 0.000 abstract 2
- 235000011478 zinc gluconate Nutrition 0.000 abstract 2
- 239000011670 zinc gluconate Substances 0.000 abstract 2
- 241000711798 Rabies lyssavirus Species 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 229960003127 rabies vaccine Drugs 0.000 abstract 1
- 210000001550 testis Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/315—Zinc compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/205—Rhabdoviridae, e.g. rabies virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/16—Masculine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Reproductive Health (AREA)
- Tropical Medicine & Parasitology (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gynecology & Obstetrics (AREA)
- Dermatology (AREA)
- Urology & Nephrology (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
Abstract
Un método para inducir una respuesta inmunitaria mediante la inyección de un inmunógeno en los testículos de un sujeto. Reivindicación 5: Una composición para la inyección intratesticular que comprende un esterilizante químico y un inmunógeno capaz de inducir una respuesta inmunitaria, dicho esterilizante químico comprende gluconato de cinc y un aminoácido capaz de formar una solución acuosa, dicho gluconato de cinc y aminoácido se encuentran. presentes en cantidades moles sustancialmente iguales y con una concentración en el intervalo de alrededor de 0.05 M a 2.0 M y neutralizados a un pH de alrededor de 6.0 a alrededor de 7.5. Reivindicación 7: La composición de la reivindicación 6, donde la vacuna para la rabia contiene un virus de la rabia inactivado.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US13/837,755 US20140271716A1 (en) | 2013-03-15 | 2013-03-15 | Intra-testicular Injection of Immunogens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR095503A1 true AR095503A1 (es) | 2015-10-21 |
Family
ID=50721871
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP140101108A AR095503A1 (es) | 2013-03-15 | 2014-03-14 | Inyección intratesticular de inmunógenos |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20140271716A1 (es) |
| AR (1) | AR095503A1 (es) |
| TW (1) | TW201442724A (es) |
| WO (1) | WO2014150718A1 (es) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4191746A (en) * | 1979-03-08 | 1980-03-04 | All India Institute Of Medical Sciences | Sterilization process for mammals |
| US5070080A (en) | 1988-08-10 | 1991-12-03 | Fahim Mostafa S | Method of inhibiting generation, maturation, motility and viability of sperm with minerals in bioavailable form |
| US7276535B1 (en) | 2003-04-14 | 2007-10-02 | Technology Transfer, Inc. | Intratesticular injection of chemical sterilant |
| EP2148572A1 (en) * | 2007-04-18 | 2010-02-03 | Fahim Technology, Inc. | Method for improving the quality of meat by reducing boar taint |
| US20090088471A1 (en) | 2007-09-28 | 2009-04-02 | Min Wang | Chemical sterilant for adult male dog population control with concomitant reduction in human dog-bite acquired rabies |
| US8524247B2 (en) * | 2008-09-17 | 2013-09-03 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services, Centers For Disease Control And Prevention | Rabies virus-based recombinant immunocontraceptive compositions and methods of use |
-
2013
- 2013-03-15 US US13/837,755 patent/US20140271716A1/en not_active Abandoned
-
2014
- 2014-03-12 WO PCT/US2014/024065 patent/WO2014150718A1/en active Application Filing
- 2014-03-14 AR ARP140101108A patent/AR095503A1/es unknown
- 2014-03-14 TW TW103109597A patent/TW201442724A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20140271716A1 (en) | 2014-09-18 |
| TW201442724A (zh) | 2014-11-16 |
| WO2014150718A1 (en) | 2014-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR106582A1 (es) | Formulaciones subcutáneas de anticuerpos anti-cd38 y sus usos | |
| CL2018001053A1 (es) | Vacuna contra el virus sincicial respiratorio | |
| CL2016003281A1 (es) | Ácidos grasos y su uso en conjugación con biomoleculas | |
| BR112018075140A2 (pt) | composição na forma de uma solução aquosa injetável, e, formulação de dose única a um ph de 7 a 7,8 | |
| PE20142167A1 (es) | Anticuerpos anti-lgr5 e inmunoconjugados | |
| AR106141A1 (es) | Métodos e intermediarios para la preparación de derivados de ácidos biliares | |
| EA201790294A1 (ru) | Средства на основе флагеллина и применения, включающие эффективную вакцинацию | |
| BR112019008063A2 (pt) | anticorpos contra o vírus sincicial anti-respiratório e métodos de sua geração e uso | |
| AR101455A1 (es) | Molécula portadora | |
| ES2721309T3 (es) | Composición para preparar tagatosa y método para preparar tagatosa a partir de fructosa | |
| PH12017501370A1 (en) | Bivalent swine influenza virus vaccine | |
| AR098168A1 (es) | Formulación estable de insulina glulisina | |
| CY1125033T1 (el) | Σκευασμα μεθοτρεξατης | |
| CL2015001562A1 (es) | Método para obtener una vacuna de mycoplasma. | |
| UY36617A (es) | Proteínas de fusión inmunogénicas para el tratamiento del cáncer | |
| BR112015024860A2 (pt) | vacinas que compreendem polipeptídeos de leishmania para o tratamento e diagnóstico de leishmaniose | |
| NZ731659A (en) | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus | |
| BR112017009876A2 (pt) | processos e intermediários para a preparação de éteres de dialcano terminados em ácido alfa,ômega-dicarboxílico | |
| AR100365A1 (es) | Composición acuosa que comprende ibuprofeno y paracetamol en combinación, proceso para fabricarla y dispositivo inyector para administrarla | |
| EA201990163A1 (ru) | Консервация микроорганизмов | |
| EA201690075A1 (ru) | Способ лечения внутриклеточной инфекции | |
| EA201400235A1 (ru) | Вакцины против гриппа на основе н5 | |
| CL2016001906A1 (es) | Vacunas contra el reovirus aviar. | |
| MX2016007224A (es) | Vacuna contra el circovirus porcino tipo 2. | |
| RU2013146452A (ru) | Инъекционный или инфузионный раствор триазавирина для лечения вирусных инфекций |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |